KYGEVVI
Live / Applied — Second extension granted (statement of use) (as of 17 Sept 2025)
What this means for you
Not registered yet, but its 19 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98321189
- Mark type
- Stylized text
- Filed
- 19 Dec 2023
- Published for opposition
- 20 Aug 2024
- Attorney of record
- Kumiko Ide
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of immunological and neurological diseases and disorders
Owner
- UCB BIOSCIENCES, INC., MORRISVILLE, NC, US
- UCB BIOSCIENCES, INC., MORRISVILLE, NC, US
- ZOGENIX, INC., EMERYVILLE, CA, US
Prosecution history
- 09 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
- 18 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Sept 2025 — SOU EXTENSION 2 GRANTED
- 17 Sept 2025 — SOU EXTENSION 2 FILED
- 17 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Apr 2025 — SOU EXTENSION 1 GRANTED
- 01 Apr 2025 — SOU EXTENSION 1 FILED
- 01 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Aug 2024 — PUBLISHED FOR OPPOSITION
- 31 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Jul 2024 — ASSIGNED TO EXAMINER